Cargando…

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system

Coronavirus disease 2019 (COVID-19) has spread, at an unprecedented speed and scale, into a global pandemic, infecting more than 29 million cases worldwide across 215 countries and territories and killing more than 930,000 individuals. There is evidence that preexisting cardiac disease can render in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bing-Yin, Wang, Bin-Quan, You, Feng, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer India Pvt. Ltd. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951674/ https://www.ncbi.nlm.nih.gov/pubmed/35372743 http://dx.doi.org/10.4103/2470-7511.312592

Ejemplares similares

Coronavirus disease 2019 and cardiovascular disease
por: Song, Jenn-Yeu, et al.
Publicado: (2023)

Coronavirus disease 2019 and cardiovascular system: A narrative review
por: Kwenandar, Felix, et al.
Publicado: (2020)

Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease
por: Li, Chenze, et al.
Publicado: (2021)

Cardiovascular disease management during the coronavirus disease 2019 pandemic
por: Lee, Wen-Hsien, et al.
Publicado: (2020)

Coronavirus disease 2019 and the cardiovascular system: Impacts and implications
por: Gupta, Mohit D., et al.
Publicado: (2020)

Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
por: Narvel, Hiba, et al.
Publicado: (2021)

Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Cardiovascular system and coronavirus disease-2019 (COVID-19): mutual injuries and unexpected outcomes
por: Sobh, Eman, et al.
Publicado: (2021)

Cardiovascular comorbidities and complications associated with coronavirus disease 2019
por: Mahajan, Kunal, et al.
Publicado: (2020)

Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
por: Ma, Lulu, et al.
Publicado: (2021)

Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
por: Ye, Qing, et al.
Publicado: (2020)

Additional Value of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events in Patients With Novel Coronavirus Disease 2019 (COVID-19)
por: Li, Shuang, et al.
Publicado: (2021)

Prediction of adverse clinical outcomes in patients with coronavirus disease 2019
por: Shi, Si, et al.
Publicado: (2020)

Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease
por: Inciardi, Riccardo M., et al.
Publicado: (2020)

Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019
por: Tanwar, Vineeta, et al.
Publicado: (2020)

Decrease in Reported Rates of Cardiovascular Device-Related Adverse Events During the Coronavirus Disease 2019 Pandemic
por: Zhou, Elsa S., et al.
Publicado: (2022)

Systemic Lupus Erythematosus and Coronavirus Disease 2019
por: Cava, Antonio La
Publicado: (2021)

Coronavirus disease 2019 and cardiovascular complications: focused clinical review
por: Saeed, Sahrai, et al.
Publicado: (2021)

Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery
por: Lazaridis, Charalampos, et al.
Publicado: (2020)

Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
por: Larson, Anthony S., et al.
Publicado: (2020)

A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
por: Huang, Dong, et al.
Publicado: (2022)

Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
por: Farooq, Saba, et al.
Publicado: (2020)

Potential adverse effects of nanoparticles on the reproductive system
por: Wang, Ruolan, et al.
Publicado: (2018)

Cardiovascular Considerations in Coronavirus Disease 2019 with a Special Focus on Arrhythmia
por: Hu, Tiffany Y., et al.
Publicado: (2020)

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
por: Li, Chenxi, et al.
Publicado: (2020)

Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
por: Xiang, Hui, et al.
Publicado: (2022)

Obesity and Coronavirus Disease 2019
por: Fei, Sijia, et al.
Publicado: (2022)

Acute Kidney Injury in the 2019 Novel Coronavirus Disease
por: Qian, Jing-Yi, et al.
Publicado: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Komiyama, Maki, et al.
Publicado: (2021)

Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential
por: Haddadi, Kaveh, et al.
Publicado: (2020)

Cardiovascular Disease Mortality — China, 2019
por: Liu, Jiangmei, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccines: landscape of global studies and potential risks
por: Jiang, Hu-Da-Chuan, et al.
Publicado: (2021)

Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice
por: Damluji, Abdulla A., et al.
Publicado: (2021)

Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019
por: Hendren, Nicholas S., et al.
Publicado: (2020)

Coronavirus disease 2019: What we know?
por: He, Feng, et al.
Publicado: (2020)

Transmission dynamics model and the coronavirus disease 2019 epidemic: applications and challenges
por: Guan, Jinxing, et al.
Publicado: (2022)

Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention
por: Ishigami, Junichi, et al.
Publicado: (2021)

Diagnostic approaches and potential therapeutic options for coronavirus disease 2019
por: Khan, Z., et al.
Publicado: (2020)

Adverse effects of sympathetic activation should not be neglected during the coronavirus disease 2019 pandemic
por: Jin, Sheng, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19): latest developments in potential treatments
por: Hon, Kam Lun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2tu9cjkbccp10tpe55oqtr6tg